Profile data is unavailable for this security.
About the company
Financiere de Tubize SA is a Belgium-based holding company. The Company holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The Company promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.
- Revenue in EUR (TTM)0.00
- Net income in EUR183.85m
- Incorporated1928
- Employees--
- LocationFinanciere de Tubize SAAllee de la Recherche, 60BRUXELLES 1070BelgiumBEL
- Phone+32 476490844
- Websitehttp://www.financiere-tubize.be/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GlaxoSmithKline Pharmaceuticals Limited | 376.65m | 68.75m | 5.09bn | 3.21k | 74.10 | -- | 66.80 | 13.52 | 37.77 | 37.77 | 206.98 | -- | -- | -- | -- | 10,920,890.00 | -- | 11.01 | -- | 17.88 | 61.97 | 55.77 | 18.25 | 12.25 | -- | 490.08 | -- | 192.07 | 6.21 | 2.00 | -2.91 | 5.78 | -36.02 | 9.86 |
Glenmark Pharmaceuticals Ltd | 1.29bn | -168.98m | 5.19bn | 14.99k | -- | -- | -- | 4.02 | -55.78 | -46.50 | 425.96 | -- | -- | -- | -- | 8,020,026.00 | -- | 1.02 | -- | 1.43 | 63.93 | 59.47 | -12.71 | 1.43 | -- | 1.78 | -- | 56.98 | 1.98 | 3.67 | -1,018.93 | -- | -5.89 | 4.56 |
Beijing Tiantan Biological Products Corp | 676.20m | 160.99m | 5.27bn | 4.86k | 32.76 | 4.03 | -- | 7.80 | 0.6419 | 0.6419 | 2.70 | 5.22 | 0.3674 | 0.9077 | 222.80 | 1,097,335.00 | 11.86 | 11.71 | 17.11 | 16.50 | 53.54 | 49.39 | 32.28 | 27.71 | 3.23 | -- | 0.0074 | 16.67 | 21.57 | 12.06 | 25.99 | 16.85 | 29.67 | 38.97 |
Rohto Pharmaceutical Co Ltd | 1.76bn | 191.63m | 5.31bn | 7.26k | 26.85 | 3.15 | 21.25 | 3.02 | 132.56 | 132.56 | 1,215.22 | 1,129.95 | 0.7642 | 2.21 | 4.37 | 38,300,730.00 | 8.42 | 8.54 | 11.70 | 11.79 | 57.76 | 58.59 | 11.02 | 10.30 | 1.27 | -- | 0.1513 | 19.39 | 13.48 | 8.09 | 17.28 | 25.85 | 5.20 | 18.61 |
Beijing Tongrentang Co Ltd | 2.27bn | 216.05m | 5.48bn | 16.78k | 25.38 | 3.24 | -- | 2.42 | 1.24 | 1.24 | 13.02 | 9.72 | 0.5916 | 1.14 | 12.61 | 1,064,742.00 | 8.41 | 8.20 | 16.20 | 16.17 | 45.25 | 46.59 | 14.22 | 13.33 | 1.90 | -- | 0.186 | 30.93 | 16.19 | 4.68 | 16.92 | 8.03 | -12.01 | 13.97 |
Siegfried Holding AG | 1.36bn | 136.21m | 5.57bn | 3.80k | 38.90 | 5.50 | 24.46 | 4.08 | 29.87 | 29.87 | 299.09 | 211.39 | 0.7046 | 2.00 | 3.80 | 326,556.30 | 7.06 | 6.51 | 8.64 | 7.98 | 25.87 | 23.24 | 10.03 | 9.06 | 1.40 | 14.34 | 0.3217 | 15.26 | 3.41 | 9.87 | -28.16 | 18.34 | 17.95 | 6.72 |
Financiere de Tubize SA | 0.00 | 183.85m | 5.81bn | -- | 31.62 | 3.08 | 31.62 | -- | 4.13 | 4.13 | 0.00 | 42.45 | 0.00 | -- | -- | -- | 9.64 | 7.04 | 9.85 | 7.24 | -- | -- | -- | 145.70 | -- | -- | 0.0161 | 20.94 | -- | -- | 3.50 | -20.93 | -- | 11.61 |
Ono Pharmaceutical Co Ltd | 3.16bn | 764.23m | 6.01bn | 3.85k | 7.53 | 1.11 | 6.84 | 1.90 | 253.57 | 253.57 | 1,052.07 | 1,726.26 | 0.5117 | 2.44 | 3.65 | 129,855,200.00 | 12.38 | 11.95 | 15.14 | 13.73 | 74.69 | 74.11 | 24.20 | 23.89 | 1.32 | -- | 0.1661 | 32.25 | 12.41 | 11.73 | 13.53 | 19.95 | -6.79 | 12.20 |
Jazz Pharmaceuticals PLC | 3.52bn | 355.36m | 6.20bn | 2.80k | 19.16 | 1.83 | 6.59 | 1.76 | 5.82 | 5.82 | 57.26 | 60.94 | 0.3457 | 0.6914 | 5.98 | 1,396,387.00 | 3.51 | 1.48 | 3.94 | 1.62 | 89.39 | 88.79 | 10.14 | 4.26 | 2.02 | 2.27 | 0.6027 | 0.00 | 4.78 | 15.19 | 285.14 | -1.49 | -20.04 | -- |
Elanco Animal Health Inc | 4.04bn | -1.13bn | 6.36bn | 9.30k | -- | 1.19 | -- | 1.57 | -2.55 | -2.55 | 9.09 | 12.02 | 0.3039 | 1.22 | 4.49 | 483,010.80 | -8.49 | -3.27 | -9.33 | -3.65 | 55.19 | 54.28 | -27.94 | -11.53 | 1.75 | 1.11 | 0.4886 | -- | 0.136 | 7.57 | -1,478.21 | -- | 2.74 | -- |
CSPC Pharmaceutical Group Ltd | 4.01bn | 751.69m | 6.37bn | 20.30k | 8.46 | 1.44 | 13.95 | 1.59 | 0.5496 | 0.5496 | 2.93 | 3.22 | 0.6914 | 3.01 | 5.24 | 1,479,853.00 | 13.25 | 16.08 | 17.64 | 21.57 | 71.38 | 72.95 | 19.16 | 19.63 | 2.22 | 84.54 | 0.0106 | 35.51 | 1.66 | 12.16 | -3.58 | 13.77 | -2.58 | 25.33 |
Data as of Sep 18 2024. Currency figures normalised to Financiere de Tubize SA's reporting currency: Euro EUR
Holder | Shares | % Held |
---|---|---|
BNP Paribas Asset Management Europe SASas of 29 Nov 2023 | 97.71k | 0.22% |
Investor Asset Management BVas of 06 Sep 2024 | 71.55k | 0.16% |
Capricorn Venture Partners NV (Investment Management)as of 31 Jul 2024 | 59.79k | 0.13% |
Value Square NVas of 30 Jun 2024 | 56.94k | 0.13% |
Sunline Pte Ltd.as of 28 Jun 2024 | 53.83k | 0.12% |
Richelieu Gestionas of 30 Apr 2024 | 40.60k | 0.09% |
Fidelity Management & Research Co. LLCas of 31 Jul 2024 | 39.16k | 0.09% |
Degroof Petercam Asset Management SAas of 31 May 2024 | 32.95k | 0.07% |
KBC Asset Management NVas of 31 Dec 2023 | 25.81k | 0.06% |
Bank Nagelmackers NVas of 12 Sep 2024 | 22.12k | 0.05% |
More ▼
Data from 31 Mar 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.